newsfilter
← Latest News
GlobeNewswire·

Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference

PITTSBURGH, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc., (NASDAQ:LIPO) ("Lipella," "our," "us" or the "Company"), a pioneering, clinical-stage pharmaceutical company,